The association between tumor mutational burden and prognosis is dependent on treatment context
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The association between tumor mutational burden and prognosis is dependent on treatment context
Authors
Keywords
-
Journal
NATURE GENETICS
Volume 53, Issue 1, Pages 11-15
Publisher
Springer Science and Business Media LLC
Online
2021-01-05
DOI
10.1038/s41588-020-00752-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Why Test for Proportional Hazards?
- (2020) Mats J. Stensrud et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types
- (2019) Robert M. Samstein et al. NATURE GENETICS
- Impact of prior chemotherapy or radiation therapy on tumor mutation burden in NSCLC.
- (2019) Sushma Jonna et al. JOURNAL OF CLINICAL ONCOLOGY
- Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group
- (2019) T. Eder et al. EUROPEAN JOURNAL OF CANCER
- Correlations between microsatellite instability and the biological behaviour of tumours
- (2019) Guang Yang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The mutational footprints of cancer therapies
- (2019) Oriol Pich et al. NATURE GENETICS
- Tumor mutational and indel burden: a systematic pan-cancer evaluation as prognostic biomarkers
- (2019) Hao-Xiang Wu et al. Annals of Translational Medicine
- Prognostic Impact of Tumor Mutation Burden in Patients With Completely Resected Non–Small Cell Lung Cancer: Brief Report
- (2018) Yuki Owada-Ozaki et al. Journal of Thoracic Oncology
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
- (2017) Ahmet Zehir et al. NATURE MEDICINE
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Clonal evolution of glioblastoma under therapy
- (2016) Jiguang Wang et al. NATURE GENETICS
- Classification and characterization of microsatellite instability across 18 cancer types
- (2016) Ronald J Hause et al. NATURE MEDICINE
- Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival
- (2016) Luc G.T. Morris et al. Oncotarget
- Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)
- (2015) Donavan T. Cheng et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Pan-cancer analysis of the extent and consequences of intratumor heterogeneity
- (2015) Noemi Andor et al. NATURE MEDICINE
- Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
- (2015) E. M. Van Allen et al. SCIENCE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory Receptors
- (2015) D. S. Thommen et al. Cancer Immunology Research
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evolutionary dynamics of cancer in response to targeted combination therapy
- (2013) Ivana Bozic et al. eLife
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search